Primary Cells Market

Global Primary Cells Market by Origins (Animal Primary Cells and Human Primary Cells), Types (Dermatocytes, Hematopoietic Cells, Gastrointestinal Cells, Heart Cells, Hepatocytes, Lung Cells, Cryopreserved Hepatocytes, Renal Cells, Fresh Hepatocytes, and Musculoskeletal Cells), End-users (Pharmaceutical & Biotechnology Companies and Medical, and Research Institutes), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1175
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 147
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global primary cells market size was valued at USD 970 million 2020 and is expected to reach USD 1,613 million by 2025, expanding at a CAGR of 10.07% during the forecast period, 2021–2028. The growth of the market is attributed to increasing cancer research, growing prevalence of cancer, increasing investment in medicine research, rapid expansion in the biopharmaceutical and biotechnology industry, and growing need for monoclonal antibodies.

Primary human cells of the body are isolated from normal human body tissue or blood cells, using an enzymatic or mechanical method. The primary cells are able to maintain their fundamental cellular functions. This is one of the most important factors influencing their demand. 3D cell culture, virology, cancer research, stem cell therapy, and tissue restoration are few applications where primary cells are used. Primary cell culture is beneficial for many research projects, which is anticipated to boost the market. Researchers are increasingly adopting primary cells to study cell biology and biochemistry, medication effects, cell signaling, and cell-pathogen interactions in 3D cell culture.

Market Trends, Drivers, Restraints, and Opportunities:

Drivers

  • Growing ongoing research for cancer & innovations in its treatment are estimated to fuel the market in the coming years. Use of primary cells is crucial in this research. These cells are useful for the development of cancer biomarkers and medication screening.
  • Rising use of stem cell therapy to treat cancer and genetic abnormalities increased the demand for primary cells across the world, which is projected to boost the market during the forecast period.
  • Rapid growth of technological advancements in healthcare and pharmaceutical sectors are spurring the market growth during the forecast period.
  • Increasing demand for monoclonal antibodies, rising applications in genetic engineering and virology, and growing demand from developing countries are anticipated to fuel the market in the coming years.

Restraints

  • Increasing concerns about primary cell culture contamination are projected to hinder the market growth during the forecast period. One of the most common problems in cell culture laboratories is primary cell culture contamination. Contaminated cells harm cell physiology and frequently result in inaccurate conclusions or the loss of unique cell lines.

Opportunity

  • Rising usage of primary cells in 3D cultures for advance scientific research is estimated to create immense opportunities for market players. Primary cells are widely used in 3D cultures, as they produce more accurate results than regular cell lines.

Scope of the Report

The report on the global primary cells market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

 

Global Primary Cells Market Segment Insights

Global Primary Cells Market Taxonomy

Based on origins, the market is divided into animal primary cells and human primary cells. In the primary cells market, the human primary cells segment holds the highest share. The human primary cell segment is expected to account for a key share of the market during the forecast period, due to growing use of human primary cells in the development of new cancer medicines and rising financing for cell therapy research and development.

In terms of types, the global primary cells market is segregated into dermatocytes, hematopoietic cells, gastrointestinal cells, heart cells, hepatocytes, lung cells, cryopreserved hepatocytes, renal cells, fresh hepatocytes, and musculoskeletal cells. The hematopoietic cells segment is anticipated to dominate the market during the forecast period, due to rising number of cell research projects and increasing pervasiveness of blood cancer.

Based on end-users, the market is segmented into pharmaceutical & biotechnology companies and medical and research institutes. The pharmaceutical & biotechnology companies’ segment is projected to represent a key share of the market during the forecast period, as these companies use primary cells as drug carriers and for cytotoxicity of new drugs.

On the basis of regions, the global primary cells market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market at a high CAGR during the forecast period. The regional market growth is attributed to increasing number of players releasing new human primary cells for research, expansion of the pharmaceutical and biotechnology sectors, growing focus on R&D, and rising prevalence of cancer in the region.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Primary Cells Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Primary Cells Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Primary Cells Market - Supply Chain
  4.5. Global Primary Cells Market Forecast
     4.5.1. Primary Cells Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Primary Cells Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Primary Cells Market Absolute $ Opportunity
5. Global Primary Cells Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Primary Cells Market Size and Volume Forecast by Types
     5.3.1. Dermatocytes
     5.3.2. Hematopoietic Cells
     5.3.3. Gastrointestinal Cells
     5.3.4. Heart Cells
     5.3.5. Hepatocytes
     5.3.6. Lung Cells
     5.3.7. Cryopreserved Hepatocytes
     5.3.8. Renal Cells
     5.3.9.
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Primary Cells Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Primary Cells Market Size and Volume Forecast by End Users
     6.3.1. Pharmaceutical & Biotechnology Companies
     6.3.2. Medical and Research Institutes
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Primary Cells Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Primary Cells Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Primary Cells Demand Share Forecast, 2019-2026
8. North America Primary Cells Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Primary Cells Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Primary Cells Market Size and Volume Forecast by Types
     8.4.1. Dermatocytes
     8.4.2. Hematopoietic Cells
     8.4.3. Gastrointestinal Cells
     8.4.4. Heart Cells
     8.4.5. Hepatocytes
     8.4.6. Lung Cells
     8.4.7. Cryopreserved Hepatocytes
     8.4.8. Renal Cells
     8.4.9.
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Primary Cells Market Size and Volume Forecast by End Users
     8.7.1. Pharmaceutical & Biotechnology Companies
     8.7.2. Medical and Research Institutes
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Primary Cells Demand Share Forecast, 2019-2026
9. Latin America Primary Cells Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Primary Cells Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Primary Cells Market Size and Volume Forecast by Types
     9.4.1. Dermatocytes
     9.4.2. Hematopoietic Cells
     9.4.3. Gastrointestinal Cells
     9.4.4. Heart Cells
     9.4.5. Hepatocytes
     9.4.6. Lung Cells
     9.4.7. Cryopreserved Hepatocytes
     9.4.8. Renal Cells
     9.4.9.
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Primary Cells Market Size and Volume Forecast by End Users
     9.7.1. Pharmaceutical & Biotechnology Companies
     9.7.2. Medical and Research Institutes
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Primary Cells Demand Share Forecast, 2019-2026
10. Europe Primary Cells Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Primary Cells Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Primary Cells Market Size and Volume Forecast by Types
     10.4.1. Dermatocytes
     10.4.2. Hematopoietic Cells
     10.4.3. Gastrointestinal Cells
     10.4.4. Heart Cells
     10.4.5. Hepatocytes
     10.4.6. Lung Cells
     10.4.7. Cryopreserved Hepatocytes
     10.4.8. Renal Cells
     10.4.9.
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Primary Cells Market Size and Volume Forecast by End Users
     10.7.1. Pharmaceutical & Biotechnology Companies
     10.7.2. Medical and Research Institutes
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Primary Cells Demand Share Forecast, 2019-2026
11. Asia Pacific Primary Cells Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Primary Cells Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Primary Cells Market Size and Volume Forecast by Types
     11.4.1. Dermatocytes
     11.4.2. Hematopoietic Cells
     11.4.3. Gastrointestinal Cells
     11.4.4. Heart Cells
     11.4.5. Hepatocytes
     11.4.6. Lung Cells
     11.4.7. Cryopreserved Hepatocytes
     11.4.8. Renal Cells
     11.4.9.
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Primary Cells Market Size and Volume Forecast by End Users
     11.7.1. Pharmaceutical & Biotechnology Companies
     11.7.2. Medical and Research Institutes
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Primary Cells Demand Share Forecast, 2019-2026
12. Middle East & Africa Primary Cells Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Primary Cells Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Primary Cells Market Size and Volume Forecast by Types
     12.4.1. Dermatocytes
     12.4.2. Hematopoietic Cells
     12.4.3. Gastrointestinal Cells
     12.4.4. Heart Cells
     12.4.5. Hepatocytes
     12.4.6. Lung Cells
     12.4.7. Cryopreserved Hepatocytes
     12.4.8. Renal Cells
     12.4.9.
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Primary Cells Market Size and Volume Forecast by End Users
     12.7.1. Pharmaceutical & Biotechnology Companies
     12.7.2. Medical and Research Institutes
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Primary Cells Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Primary Cells Market: Market Share Analysis
  13.2. Primary Cells Distributors and Customers
  13.3. Primary Cells Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. ZenBio Inc.
     13.4.2. Stem Cell Technologies
     13.4.3. Promocell
     13.4.4. ALLCells
     13.4.5. Cell Applications Inc.
     13.4.6. Sigma-Aldrich
     13.4.7. Thermo Fisher Scientific
     13.4.8. Cureline
     13.4.9.
Segments Covered in the Report:
By Origins
  • Animal Primary Cells
  • Human Primary Cells
By Types
  • Dermatocytes
  • Hematopoietic Cells
  • Gastrointestinal Cells
  • Heart Cells
  • Hepatocytes
  • Lung Cells
  • Cryopreserved Hepatocytes
  • Renal Cells
  • Fresh Hepatocytes
  • Musculoskeletal Cells
By End-users
  • Pharmaceutical & Biotechnology Companies
  • Medical and Research Institutes
By Regions
  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East & Africa
By Key Players
  • ZenBio Inc.
  • Stem Cell Technologies
  • Promocell
  • ALLCells
  • Cell Applications Inc.
  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • Cureline
  • American Type Culture Collection
  • Lonza Group
  • Cell Applications Inc.
  • Pelobiotech
  • Axol Bioscience Ltd
  • Cell Biologics Inc. AG
  • Creative Bioarray

Key players in the primary cells market include ZenBio, Inc., Stem Cell Technologies, Promocell, ALLCells, Cell Applications, Inc., Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Lonza Group, Cell Applications, Inc., Pelobiotech, Axol Bioscience Ltd, Cell Biologics, Inc., AG, and Creative Bioarray.

Buy Report